COFCO Biotechnology Co., Ltd.

Sembol: 000930.SZ

SHZ

6.57

CNY

Bugünkü piyasa fiyatı

  • -21.1266

    F/K Oranı

  • -2.7465

    PEG Oranı

  • 12.13B

    MRK Kapağı

  • 0.09%

    DIV Verimi

COFCO Biotechnology Co., Ltd. (000930-SZ) Finansal Tablolar

Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz COFCO Biotechnology Co., Ltd. (000930.SZ). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

Bilanço

COFCO Biotechnology Co., Ltd.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996

balance-sheet.row.cash-and-short-term-investments

01481.11016.61116
662.3
700.5
772.9
554.8
617.8
537.1
284.5
255.9
353.4
406.6
508.6
694
552.7
734.7
324.7
620.5
562.8
587
361.7
306.5
162.1
245.3
61.9
29.2
1.3

balance-sheet.row.short-term-investments

02.13.8-24.4
-21.1
-26.5
-26.4
0
5.5
0
-5.8
0.6
0.3
1.2
3.8
10
0
35.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

01549.62608.52147
4052.6
1726.9
2861.6
688.4
469.1
509.4
826.6
694.3
566.1
626.9
558.3
380.1
539.1
1019
968.9
731.6
510.3
580.8
225.8
189.4
57.2
36.2
26.7
35.4
42

balance-sheet.row.inventory

02534.33763.24052.3
4991.5
2770
3867.3
619.1
563.4
737.8
1265.4
923
1188.3
773.6
982.5
625.3
843.3
709.6
594.6
951.6
619.2
332.6
170.8
69.2
78
40.6
36.7
28.2
23.8

balance-sheet.row.other-current-assets

0470.3282.6319.1
195
1530.5
1904.7
36.3
21.2
31.8
-189.4
-208.7
-100.9
-92.3
-70.4
-29.5
-53.9
-174.6
141.4
-48.6
-22.3
35.9
111.1
119.4
228.6
302.1
119.4
47.6
22.7

balance-sheet.row.total-current-assets

06035.376717634.4
9901.4
6727.9
9406.5
1898.6
1671.5
1816
2187.1
1664.5
2007
1714.7
1979
1669.8
1881.2
2288.8
2029.6
2255.2
1670.1
1536.2
869.4
684.5
525.9
624.2
244.8
140.3
89.9

balance-sheet.row.property-plant-equipment-net

0867886128650
8493.8
8394.1
8774.9
3397.5
3130.4
3315.9
4225.7
4420.6
4371
4283.5
4455.1
4607.6
5034.4
5065.8
5229.5
4696.8
4034.1
3001.4
2095.1
1680.8
779
431.6
245.8
167.3
100.8

balance-sheet.row.goodwill

0366366366
366
366
366
366
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0602.7610.6629.7
852.7
823.9
898.9
445.6
333
342.6
340.9
356.6
368.1
354.3
375.7
359
176.7
161.4
139
57.3
16.9
8.8
5.9
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0968.7976.6995.8
1218.8
1189.9
1265
445.6
333
342.6
340.9
356.6
368.1
354.3
375.7
359
176.7
161.4
139
57.3
16.9
8.8
5.9
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0535.4536.9536.6
538.5
592.2
610.6
39.1
33.6
0
44.9
38.5
38.8
37.9
35.3
56.4
0
39.4
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0265164.5202.8
133.3
131.7
131.9
118.9
9.3
0
46.2
40.4
35.1
45.2
73
63.6
38.1
55.7
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

075.5139.242.6
198.8
121
98.7
56.3
257.2
173.7
19.4
30.8
39.2
41.8
4.7
10.3
73.7
35.6
290.4
383.3
179
170.6
69.7
82.5
47
24.5
0
0
0

balance-sheet.row.total-non-current-assets

010522.510429.310427.7
10583.1
10429
10881
4057.3
3763.5
3832.2
4677.1
4886.9
4852.2
4762.6
4943.9
5096.9
5322.9
5357.8
5658.8
5137.3
4229.9
3180.8
2170.7
1763.3
826
456.1
245.8
167.3
100.8

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

016557.918100.318062.1
20484.5
17156.9
20287.6
5955.9
5435
5648.2
6864.2
6551.4
6859.1
6477.4
6922.9
6766.7
7204.1
7646.6
7688.5
7392.5
5900
4717.1
3040.1
2447.8
1351.9
1080.3
490.6
307.6
190.6

balance-sheet.row.account-payables

0681.9919.6920.2
845.8
854.8
984.9
315.1
309
197.3
582.2
332.6
287.8
278.3
476
564
1268
1652.7
1326.8
1511.4
1316.5
912.6
511.8
376.8
276.9
132.9
100.8
63
36.7

balance-sheet.row.short-term-debt

03398.92929.12871.7
6640.2
2731.4
5158.9
2261.2
2126.9
2461.3
2118
1908.5
2203.6
2343.1
2965.7
2986
3035.9
2781.9
2432.8
2343.8
1802.3
1413.2
783.9
389.2
198.7
139.8
58.8
52
39.7

balance-sheet.row.tax-payables

047.691.464.5
119.9
78.5
119.9
46.1
42.1
24.3
6.3
18.4
-22.6
-1.9
-13
64.1
-9.9
-50.5
-6.5
5.7
-26.3
-38.3
-11.8
-8.2
34.1
36.2
27.5
12.7
8.3

balance-sheet.row.long-term-debt-total

0165.6296.9523.7
189.7
274.7
645
535.3
377.8
564.1
688.3
779.1
853.1
373
413.6
562.3
603
983
1110
591.3
884.9
630.2
190.5
115.2
170.2
178.2
112.3
65.8
19.9

Deferred Revenue Non Current

056.55950.9
64.5
67.5
62.6
18
18.9
20.6
44.2
48.2
0
0
0
0
0
-912.9
0
0
0
0
0
0
0
-178.2
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0794.71034.132.4
55.9
1633.6
3541.2
33.1
37
19.9
45.2
58.2
54.3
58.8
63.5
37.3
44.8
66.4
544.3
95.2
55.9
28.4
15.1
3.7
3.3
1.8
0.8
0.9
2.1

balance-sheet.row.total-non-current-liabilities

0492.5427.3712.9
359.3
412.7
836.9
741.2
944.7
1108
754.6
831
942.7
617.2
438.9
592.2
616.9
1054.4
1177.6
591.4
889.5
637.2
191.2
116.3
173.6
183.9
112.3
65.8
19.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0196.6105.6117.3
121.7
17.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

05634.35588.86303.4
9682.7
6954
10641.7
3994.5
3729.2
4074.5
3760.4
3457.9
3790
3538.7
4321.2
4425
5169.6
5734.5
5667.4
4957.5
4111.9
3105.2
1534.1
1067.2
759.8
508.4
340.3
208.6
122.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

01864.71865.31865.7
1865.8
1847.6
1847.6
964.4
964.4
964.4
964.4
964.4
964.4
964.4
964.4
964.4
964.4
964.4
964.4
964
391.9
318.6
318.6
177
147
147
87
44.8
43

balance-sheet.row.retained-earnings

01411.73152.32601.3
1645.1
1060.4
514.4
-278.2
-500.4
-627.5
809.8
802.4
788.9
676.3
390.2
185.5
-50.2
-108.5
-50
339.6
273.4
273.4
192.4
127.2
56.2
49
15.6
46.1
21.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

01226.61131.5989.9
888.8
996.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

05948.55950.85940.4
5994
5923
6864.1
1117.6
1096.9
1098.7
1114.6
1105.4
1086.3
1074.9
1027.8
973.4
931.5
960.1
1002.6
993.8
1080
997.9
979.2
1065.8
388.9
376
47.7
8.1
3.7

balance-sheet.row.total-stockholders-equity

010451.612099.911397.4
10393.7
9827.4
9226.1
1803.8
1560.9
1435.6
2888.9
2872.2
2839.7
2715.7
2382.4
2123.3
1845.8
1816
1917
2297.5
1745.3
1589.9
1490.1
1370.1
592.1
571.9
150.3
99
67.9

balance-sheet.row.total-liabilities-and-stockholders-equity

016557.918100.318062.1
20484.5
17156.9
20287.6
5955.9
5435
5648.2
6864.2
6551.4
6859.1
6477.4
6922.9
6766.7
7204.1
7646.6
7688.5
7392.5
5900
4717.1
3040.1
2447.8
1351.9
1080.3
490.6
307.6
190.6

balance-sheet.row.minority-interest

0402411.6361.3
408.1
375.5
419.8
157.6
144.9
138.2
214.9
221.3
229.4
223.1
219.3
218.4
188.7
96.1
104.1
137.6
42.8
21.9
15.9
10.5
0
0
0
0
0

balance-sheet.row.total-equity

010853.612511.511758.7
10801.8
10202.9
9645.8
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0535.4536.9512.1
517.3
565.7
584.2
39.1
39.1
39.1
39.1
39.1
39.1
39.1
39.1
66.4
73.7
74.9
290.4
383.3
179
170.6
69.7
82.3
47
24.5
0
0
0

balance-sheet.row.total-debt

03761.132263395.4
6829.9
3006.1
5804
2796.5
2504.7
3025.3
2806.3
2687.6
3056.8
2716.1
3379.3
3548.3
3638.9
3764.9
3542.8
2935.1
2687.2
2043.4
974.4
504.4
368.9
318
171.1
117.8
59.5

balance-sheet.row.net-debt

022802209.42279.5
6167.6
2305.6
5031
2241.7
1892.4
2488.3
2521.8
2432.3
2703.7
2310.8
2874.5
2864.3
3086.3
3065.7
3218.1
2314.6
2124.4
1456.4
612.7
197.9
206.8
72.7
109.2
88.6
58.2

Nakit Akış Tablosu

COFCO Biotechnology Co., Ltd.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

01060.91133628.2
558.9
517.4
249.7
133.2
-1495
31.6
50.5
201.5
361.3
301.2
279.9
61.7
17.3
-384.8
139.1
107.1
104.7
114.1
110
86
40.6
15.6

cash-flows.row.depreciation-and-amortization

0458.2446.3436.4
425.3
609.5
181.1
168.1
275.7
271.5
256.5
241.9
260.1
250.2
267.3
222.6
266.4
299.2
207.2
126.6
73
61.2
41.7
31.1
15.2
4.6

cash-flows.row.deferred-income-tax

036.1-62.2-3.3
-0.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-562.23.3
0.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-1261.92701.8-4471.1
1670.7
-2886.4
88
340.8
190.7
-233.6
254.1
-384.4
-185.6
-477.1
-324.4
-233
675.7
-270.7
-95.3
23
-79.6
-10.4
-80.2
-16
-251.5
-22

cash-flows.row.account-receivables

0-1051.92418.2-2276.3
960.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

083.1760.3-2462.3
983.4
-1741.4
-117.8
257
418.1
-289.3
264.8
-413.8
179.8
-357.2
218.1
-133.8
-115
357
-332.4
-286.5
-161.9
-101.3
-22.7
-37.3
-3.9
0

cash-flows.row.account-payables

0-329.1-414.5270.7
-273
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

036.1-62.2-3.3
-0.5
-1145
205.8
83.7
-227.3
55.6
-10.7
29.5
-365.3
-119.9
-542.5
-99.2
790.7
-627.7
237.1
309.5
82.3
90.9
-57.5
21.4
-247.6
0

cash-flows.row.other-non-cash-items

0420.1560.4495.7
994.9
836.3
228.9
142.5
914.3
137.3
176.6
209.7
258
239
366.7
387.4
126
428
134.2
81.5
46.2
25.2
20.2
25.7
51.5
21.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-565.8-1109.8-987.5
-900.8
-868.4
-639.2
-160.5
-83.9
-129.5
-240.6
-160.7
-149.9
-178.4
-162.4
-243.9
-337.2
-444.8
-726.1
-703.4
-790.9
-503.3
-678.1
-160.4
-171.6
-7.2

cash-flows.row.acquisitions-net

0305.7160.5107.8
151.7
0
7449.1
0
0
0
0
-19.7
0
0
0.5
0
337.2
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-32.6270.4-21.1
-32
0
-6740.9
0
0
0
0
170.9
0
0
-30.7
0
-45
-2.3
-354.3
-35.6
-238
-3.8
-58.5
-22.5
-17.5
0

cash-flows.row.sales-maturities-of-investments

014.81.66.3
106.7
47.2
2.2
5.8
5.8
5.7
3.7
3.7
3.7
32.2
6.7
5.7
191.9
2.3
8
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0-22.79.4-4.5
44
-33.5
-639.2
13.8
0.6
1.2
7.9
-160.7
8.8
1.3
33.5
32.3
-337.2
107
10.2
-92.2
111.9
0.9
0.2
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-300.6-667.9-899
-630.4
-854.7
-568
-140.9
-77.5
-122.6
-229.1
-166.5
-137.5
-145
-152.5
-205.8
-190.3
-337.8
-1062.3
-831.2
-917
-506.2
-736.5
-182.9
-189
-7.2

cash-flows.row.debt-repayment

0-6493.2-11592.7-5566.1
-8894.5
-7613.7
-2708.1
-3325.4
-3293.6
-3140.6
-2970.4
-3654.9
-3599.2
-4020.9
-3431
-3059.1
-3342.8
-2557.6
-1954.6
-2032.2
-1003.6
-797.2
-268.2
-170.9
-192.9
-38.7

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-554.7-277.3-164.4
-196
-191.5
-114.7
-131.3
-180.7
-166.1
-181.8
-212.7
-200.4
-197.6
-242.6
-302
-233.8
-206.1
-137.7
-118.6
-73.7
-41.3
-25.9
-90.6
-14.1
-7.8

cash-flows.row.other-financing-activites

06453.78168.49485.1
6000.6
9127.9
2588
2895.5
3895.4
3253.9
2550.8
3715.9
3150.3
3878.2
3367.9
2989.2
3064.9
2741.1
2829.9
2619.7
2068.7
1208.9
1083.1
234.4
723.7
79.1

cash-flows.row.net-cash-used-provided-by-financing-activities

0-594.3-3701.73754.6
-3089.9
1322.7
-234.8
-561.2
421
-52.9
-601.3
-151.7
-649.3
-340.3
-305.7
-371.8
-511.7
-22.6
737.6
468.9
991.3
370.3
789
-27.1
516.7
32.6

cash-flows.row.effect-of-forex-changes-on-cash

040.4-4.3-0.5
1.4
5.7
0.5
2.3
-4.8
-2.1
-5.1
-2.8
-6.6
-7.2
0.1
-7.6
-8.8
-7.2
-2.8
-0.1
6.5
0.9
0.2
0
0
0

cash-flows.row.net-change-in-cash

0-146.1467.7-55.8
-69.2
-449.6
-54.7
85
224.6
29.2
-97.8
-52.2
-99.5
-179.1
131.3
-146.5
374.5
-295.8
57.6
-24.1
225.3
55.2
144.4
-83.1
183.4
44.9

cash-flows.row.cash-at-end-of-period

09631109.1641.4
697.2
766.4
539.4
594.1
509.1
284.5
255.3
353.1
405.4
504.8
684
552.7
699.2
324.7
620.5
562.8
587
361.7
306.5
162.1
245.3
61.9

cash-flows.row.cash-at-beginning-of-period

01109.1641.4697.2
766.4
1216
594.1
509.1
284.5
255.3
353.1
405.4
504.8
684
552.7
699.2
324.7
620.5
562.8
587
361.7
306.5
162.1
245.3
61.9
16.9

cash-flows.row.operating-cash-flow

0708.44841.6-2910.9
3649.7
-923.3
747.7
784.7
-114.2
206.8
737.7
268.7
693.9
313.3
589.4
438.7
1085.3
71.7
385.2
338.3
144.4
190.1
91.7
126.8
-144.2
19.5

cash-flows.row.capital-expenditure

0-565.8-1109.8-987.5
-900.8
-868.4
-639.2
-160.5
-83.9
-129.5
-240.6
-160.7
-149.9
-178.4
-162.4
-243.9
-337.2
-444.8
-726.1
-703.4
-790.9
-503.3
-678.1
-160.4
-171.6
-7.2

cash-flows.row.free-cash-flow

0142.73731.8-3898.4
2748.9
-1791.7
108.4
624.2
-198.1
77.2
497.1
108
544
134.9
427
194.8
748.1
-373
-341
-365.1
-646.5
-313.1
-586.4
-33.6
-315.8
12.3

Gelir Tablosu Satırı

COFCO Biotechnology Co., Ltd.'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin 000930.SZ brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996

income-statement-row.row.total-revenue

020289.819918.123468.6
19909.4
19472
17703.9
6275.9
5603.4
6457.3
7153.2
7339.9
7730.4
7401.3
5967.2
5011
4801.9
4178.1
4398.2
3261.3
2198.2
1547.4
1199.4
853.2
705.2
482.9
345.6
229
102.2

income-statement-row.row.cost-of-revenue

019341.417666.620842.8
17827.7
16735.5
14803.5
5596.5
4830.8
6482.2
6463.1
6652.7
6955.5
6695.1
5758.5
4752.4
4864.9
4471
4424.6
2922
1807.2
1260.9
954.2
660.1
503.9
381.8
268.8
169.5
69.5

income-statement-row.row.gross-profit

0948.42251.52625.7
2081.7
2736.5
2900.5
679.4
772.5
-25
690.1
687.2
774.9
706.2
208.7
258.6
-63.1
-292.9
-26.4
339.4
391.1
286.5
245.2
193.1
201.3
101.1
76.8
59.5
32.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-534.275259
400.1
-258.2
3.9
104.2
215.9
76.8
119.7
202
368
652.8
891.3
871.5
871.3
819.4
324.4
214.3
13.3
2
36
19.1
3.3
0.8
1.1
0
0.1

income-statement-row.row.operating-expenses

01403.8553.1752.6
860
1130
1516.3
297
607.3
588
604.1
636.2
668.1
597.7
517.7
437.6
429.5
361.5
438.9
208.9
158
96.9
89.7
75.9
77.3
42.3
25.8
18.2
9.6

income-statement-row.row.cost-and-expenses

020745.318219.721595.5
18687.7
17865.5
16319.7
5893.6
5438.1
7070.2
7067.2
7288.9
7623.6
7292.8
6276.2
5190
5294.4
4832.5
4863.5
3130.8
1965.2
1357.7
1043.9
735.9
581.2
424.1
294.6
187.7
79.1

income-statement-row.row.interest-income

016.216.215.4
10.6
9.9
5
2.1
4.1
4.6
3.2
5.1
4.2
7.3
5.4
5.5
8
36.2
37.6
12.8
5.3
5.9
2.5
7.1
2.3
0
0
0
0

income-statement-row.row.interest-expense

0112.887.1157.8
94.3
162.1
163.1
106.4
156
177.6
148.2
154.7
193.4
190.6
162.7
230.9
286.6
282.5
228.3
116.8
98.4
63.5
28.9
23
23.5
11.7
9.2
6.8
4.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-84.29.7-543.5
-393.5
-990.1
-766.4
-123.3
-29.4
-861.1
-26.3
3.2
158.3
389.8
640.4
502.9
561.1
693.8
125.7
80.4
-83.8
-48.2
5.1
1.2
-24.2
-11.2
-8.1
-6.9
-4.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-534.275259
400.1
-258.2
3.9
104.2
215.9
76.8
119.7
202
368
652.8
891.3
871.5
871.3
819.4
324.4
214.3
13.3
2
36
19.1
3.3
0.8
1.1
0
0.1

income-statement-row.row.total-operating-expenses

0-84.29.7-543.5
-393.5
-990.1
-766.4
-123.3
-29.4
-861.1
-26.3
3.2
158.3
389.8
640.4
502.9
561.1
693.8
125.7
80.4
-83.8
-48.2
5.1
1.2
-24.2
-11.2
-8.1
-6.9
-4.1

income-statement-row.row.interest-expense

0112.887.1157.8
94.3
162.1
163.1
106.4
156
177.6
148.2
154.7
193.4
190.6
162.7
230.9
286.6
282.5
228.3
116.8
98.4
63.5
28.9
23
23.5
11.7
9.2
6.8
4.1

income-statement-row.row.depreciation-and-amortization

0509.2888.7446.3
436.4
425.3
609.5
181.1
168.1
275.7
271.5
256.5
241.9
260.1
250.2
267.3
222.6
266.4
299.2
207.2
126.6
73
61.2
41.7
31.1
15.2
4.6
6.7
4.1

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-455.41350.21926.6
1195.5
1656.4
614.2
154.9
-57.8
-1547.6
-57.1
-144
-96.8
-144.2
-557.7
-539.8
-802.8
-780
-687.9
26.9
159.2
146.6
133.5
102.7
99.3
47.3
41.8
34.6
19

income-statement-row.row.income-before-tax

0-539.71359.91383.1
801.9
666.3
617.8
259.1
135.9
-1474.1
59.7
54.1
265
498.2
331.3
324
68.6
39.4
-351.5
226
160.9
145
165.1
120.1
101.2
47.8
42.9
34.5
19

income-statement-row.row.income-tax-expense

073.8298.9250.1
173.8
107.5
100.4
9.4
2.6
20.9
28.1
3.7
63.6
136.9
59.9
44.1
34.7
22.2
30.9
70.2
53.8
40.3
51
10.1
15.2
7.2
6.4
5.2
2.9

income-statement-row.row.net-income

0-601.61058.51129.6
593.1
592.8
483
237.3
127.1
-1418
35.2
50.7
183
355.1
263.9
251.9
26.4
25.8
-384.8
139.1
101.1
98.8
110.2
110
86
40.6
36.5
29.3
16.2

Sıkça Sorulan Sorular

Nedir COFCO Biotechnology Co., Ltd. (000930.SZ) toplam varlıklar?

COFCO Biotechnology Co., Ltd. (000930.SZ) toplam varlıklar 16557861385.000 şeklindedir.

İşletmenin yıllık geliri nedir?

Yıllık gelir N/A'dur.

Firma kâr marjı nedir?

Firma kar marjı 0.056'dir.

Şirket serbest nakit akışı nedir?

Serbest nakit akışı 1.426'dur.

İşletme net kar marjı nedir?

Net kâr marjı -0.028'dir.

Firma toplam geliri nedir?

Toplam gelir -0.025'dur.

Nedir COFCO Biotechnology Co., Ltd. (000930.SZ) net kar (net gelir)?

Net kar (net gelir) -601629843.000'dur.

Firmanın toplam borcu nedir?

Toplam borç 3761143669.000'dir.

Faaliyet giderleri rakamı nedir?

İşletme giderleri 1403828205.000'dır.

Şirket nakit rakamı nedir?

İşletme içi nakit 0.000'tir.